NCT06696534Recruiting
Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme
Source: ClinicalTrials.gov · Last updated 2 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are: * Values of experience of participants into screening programme. * Values of preferences of participants for screening methods. Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1000 (estimated)
- First submitted
- 12 Nov 2024
- Start date
- 19 May 2025
- Primary completion date
- Nov 2025
- Lead sponsor
- ADVANCED MARKER DISCOVERY S.L.
- Diseases
- Colorectal cancer
- NCT number
- NCT06696534
What you commit to
- Study type: Interventional
- Planned participants: 1000
- From 19 May 2025 to the primary completion date, Nov 2025
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants with a previous colonoscopy in consequence of a FOBT positive result.
Other
- Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form.
- Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.
Who the study is looking for
- Participants ages from 50 to 69 years (both included) at the time of informed consent signed.
- Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center.
- Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form.
Age in the registry: 50 years to 69 years · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CS Mar Báltico Coordinator of this site? Confirm its status | Madrid | Spain | Recruiting |
| UCSP Sete Rios Coordinator of this site? Confirm its status | Lisbon | Portugal | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.